TNF and inflammatory bowel disease: Taken together, our results suggest that the use of TNF-α-antagonists is clearly associated with attenuated IgG antibody response against SARS-CoV-2 in fully vaccinated patients with IBD, while the use of thiopurines may also be potentially associated with an attenuated serological response.